Skystar Capital

Skystar Capital is a Jakarta-based early-stage venture firm investing across Southeast Asian technology companies, with a generalist mandate that includes consumer internet, fintech, marketplaces, and selectively digital health. Stage focus is seed and Series A, with checks typically in the $250k to $1M range. Healthcare exposure is concentrated in digital health platforms, telehealth, and B2C health products serving Indonesian and broader Southeast Asian markets; the firm does not publicly position as an AI-first investor and is not the right fit for founders whose pitch hinges on novel AI architecture. Physician founders building Indonesian- or Southeast Asian-anchored digital health, telehealth services, or care-coordination platforms with credible local commercial momentum are the right profile. Founders building therapeutics, devices with US-only regulatory paths, or US-only commercial models should pitch elsewhere. Geographic posture is Southeast Asia-anchored with a Jakarta center of gravity. The realistic entry path is a warm introduction from an Indonesian or broader Southeast Asian ecosystem operator, an existing portfolio founder, or a co-investing regional seed fund; the firm is well known to the Jakarta ecosystem and prefers referred deals. Founders should arrive with traction signal, defended unit economics calibrated to Southeast Asian market realities, and a credible regional expansion plan. Treat Skystar Capital as a thesis-aligned regional seed partner that brings deep local network value for digital health founders building for Indonesia and the broader Southeast Asian opportunity.